Merck KGaA (OTCMKTS:MKGAF - Get Free Report) shares saw an uptick in trading volume on Monday . 2,343 shares were traded during trading, an increase of 126% from the previous session's volume of 1,039 shares.The stock last traded at $130.86 and had previously closed at $130.40.
Merck KGaA Price Performance
The stock's 50 day moving average is $131.65 and its two-hundred day moving average is $138.33. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The stock has a market capitalization of $17.71 billion, a PE ratio of 20.92 and a beta of 0.96.
About Merck KGaA
(
Get Free Report)
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
See Also
Before you consider Merck KGaA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck KGaA wasn't on the list.
While Merck KGaA currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access Sale